Literature DB >> 6244563

Colchicine inhibits epidermal growth factor degradation in 3T3 cells.

K D Brown, M Friedkin, E Rozengurt.   

Abstract

Colchicine (2 microM) did not affect the initial rate of association of 125I-labeled epidermal growth factor (125I-EGF) to Swiss 3T3 cells but continued incubation (up to 24 hr) led to an increase in cell-associated radioactivity. The effect is also produced by Colcemid, vinblastine, and podophyllotoxin but not by lumicolchicine. Disruption of microtubules with colchicine does not alter the rate of "down regulation" of EGF receptors, suggesting the binding and internalization of the factor proceed unchanged. However, colchicine markedly decreases the rate of appearance of acid-soluble radioactivity from cells either incubated continuously with 125I-EGF for 24 hr or exposed to the radioactive peptide for only 1 or 3 hr. The results indicate that colchicine decreases the rate of degradation of internalized 125I-EGF. Because antitubulin agents enhance the mitogenic effect of EGF our results suggest that peptide degradation can be dissociated from the long-term biological effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244563      PMCID: PMC348295          DOI: 10.1073/pnas.77.1.480

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  An 18,000 molecular weight polypeptide induces early events and stimulates DNA synthesis in cultured cells.

Authors:  H R Bourne; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

2.  A comparison of the binding of epidermal growth factor to cultured granulosa and luteal cells.

Authors:  I Vlodavsky; K D Brown; D Gospodarowicz
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

3.  Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells.

Authors:  A Aharonov; R M Pruss; H R Herschman
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

4.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

5.  Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.

Authors:  R M Pruss; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor.

Authors:  M Das; C F Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

7.  Binding, internalization, and degradation of epidermal growth factor by balb 3T3 and BP3T3 cells: relationship to cell density and the stimulation of cell proliferation.

Authors:  K D Brown; Y C Yeh; R W Holley
Journal:  J Cell Physiol       Date:  1979-08       Impact factor: 6.384

8.  Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts.

Authors:  G Carpenter; K J Lembach; M M Morrison; S Cohen
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

9.  The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes.

Authors:  S E Malawista; P T Bodel
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  13 in total

Review 1.  Epidermal growth factor receptors.

Authors:  E D Adamson; A R Rees
Journal:  Mol Cell Biochem       Date:  1981-02-11       Impact factor: 3.396

2.  Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine.

Authors:  J Blay; K D Brown
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

3.  Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus.

Authors:  Sanna Suikkanen; Tuula Aaltonen; Marjukka Nevalainen; Outi Välilehto; Laura Lindholm; Matti Vuento; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts.

Authors:  M Korc; L M Matrisian; B E Magun
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Microtubule disruption stimulates DNA synthesis in bovine endothelial cells and potentiates cellular response to basic fibroblast growth factor.

Authors:  L Liaw; S M Schwartz
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Inhibition of cardiac proteolysis by colchicine. Selective effects on degradation of protein subclasses.

Authors:  J S Crie; J M Ord; J R Wakeland; K Wildenthal
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

7.  Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.

Authors:  K D Brown; D M Blakeley; P Roberts; R J Avery
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

8.  Antibody-induced modulation of proteins in vesicular stomatitis virus-infected fibroblasts.

Authors:  E J O'Rourke; W H Guo; A S Huang
Journal:  Mol Cell Biol       Date:  1983-09       Impact factor: 4.272

9.  Epidermal growth factor stimulation of ornithine decarboxylase activity in a human hepatoma cell line.

Authors:  D M Moriarity; D M DiSorbo; G Litwack; C R Savage
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand-induced receptor down-regulation.

Authors:  I Zachary; E Rozengurt
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.